Delpor
PrivateLast Round
Grant
Nov 16, 2021
Total Funding Raised
$10.26M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Delpor operates in Healthcare & Life Sciences and is based in Brisbane, California. Its latest recorded funding round was a Grant round in November 2021.
Delpor is a clinical-stage biopharmaceutical company that develops once-yearly therapies for chronic diseases using innovative subcutaneous implant technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delpor Comparables
Compare Delpor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoMedical Systems | 86% | |
| ReacX Pharmaceuticals, Inc. | 84% | |
| Black Titan Corporation | 83% |
For institutional investors. Book with your work email.
Delpor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 16, 2021 | ||||
| Grant | Oct 14, 2019 | ||||
| Grant | Jun 14, 2017 | ||||
| Grant | Feb 9, 2017 | ||||
| Series A | Mar 28, 2016 | ||||
Grant | Jun 20, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Delpor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
| Fondazione Hub Innovazione Trentino | VC Round |
| NIH RADx | Grant |
| Cloudstone Capital | VC Round |
| Kairos Ventures | Series A |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Ulu Ventures | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 2314% MoM, from 119 to 2.9K.
- Jul 20, 2026
Hired 5 new employees, representing 100% of headcount.
For institutional investors. Book with your work email.
Delpor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Delpor's valuation, stock price, and market status.
Is Delpor a public or private company?
Delpor is a private company.
What is the current stock price of Delpor?
Delpor is a private company, so its shares have no public market price. Caplight tracks Delpor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Delpor worth (valuation)?
Valuation information for Delpor is not publicly available.
Can I buy Delpor stock?
Delpor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Delpor's last funding round?
Delpor's most recent funding round was Grant on November 16, 2021.
Who are the main investors in Delpor?
Key investors in Delpor include National Institute of Mental Health, NIH RADx, Kairos Ventures, National Institute of Diabetes and Digestive and Kidney Diseases.
Will Delpor IPO soon?
No public IPO plans have been announced for Delpor.
How can I track Delpor secondary market activity?
Caplight tracks bids, offers, and trades in Delpor's shares on secondary markets.